93 results
Page 2 of 5
DEFA14A
e5b6kq8 i7ly86leg
2 Jun 22
Additional proxy soliciting materials
4:30pm
424B5
e37fv8o9k
7 Jun 21
Prospectus supplement for primary offering
4:21pm
8-K/A
EX-1.1
n8zb ncwbr
7 Jun 21
Ocuphire Announces $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:05pm
8-K
EX-1.1
y4le swfzec4ts5
4 Jun 21
Ocuphire Announces $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:48pm
424B5
rzeykp 5d8m00s
11 Mar 21
Prospectus supplement for primary offering
9:19am
424B4
3f40mavg
17 Feb 21
Prospectus supplement with pricing info
7:14am
8-K/A
EX-99.3
cnyw7l5 tyal
30 Dec 20
Financial Statements and Exhibits
5:13pm
8-K
EX-3.3
26s9u
6 Nov 20
Ocuphire Pharma Completes Transactions and Begins Trading on Nasdaq as OCUP
9:18am
8-K
EX-10.8
1xfatod
6 Nov 20
Ocuphire Pharma Completes Transactions and Begins Trading on Nasdaq as OCUP
9:18am
424B3
8yc1y34e57lj
2 Oct 20
Prospectus supplement
9:25am